Continuing HIV Risk in New York City Injection Drug Users: The Association of Syringe Source and Syringe Sharing

REFERENCES

• Abdul-Quader, A. S., Heckathorn, D. D., McKnight, C., Bramson, H., Nemeth, C., Sabin, K., (2006). Effectiveness of respondent-driven sampling for recruiting drug users in New York City: Findings from a pilot study. Journal of Urban Health, 83(3), 459–476.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R., Malik, M. R., Grau, L. E., Singer, M., Marshall, P., & Heimer, R. (2004). Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction, 99(9), 1136–1146.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R., Ridgeway, G., Schell, T., Anderson, R., Flynn, N., & Kral, A. (2007). Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction, 102(4), 638–646.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., & Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: A cohort study. AIDS, 14(5), 605–611.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Kral, A. H., Lorvick, J., & Watters, J. K. (1997). Impact of law enforcement on syringe exchange programs: A look at Oakland and San Francisco. Medical Anthropology, 18(1), 61–83.
   PubMedGoogle Scholar
• Brogly, S. B., Bruneau, J., Vincelette, J., Lamothe, F., & Franco, E. L. (2000). Risk behaviour change and HIV infection among injection drug users in Montreal. AIDS, 14(16), 2575–2582.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2007). Syringe exchange programs—United States, 2005. MMWR. Morbidity and Mortality Weekly Report, 56(44), 1164–1167.
   PubMedGoogle Scholar
• Clatts, M. C., Goldsamt, L., Neaigus, A., & Welle, D. L. (2003). The social course of drug injection and sexual activity among YMSM and other high-risk youth: An agenda for future research. Journal of Urban Health, 80(4 Suppl. 3), iii26–iii39.
   PubMed Web of Science ®Google Scholar
• Coffin, P. (2000). Syringe availability as HIV prevention: A review of modalities. Journal of Urban Health, 77(3), 306–330.
   PubMed Web of Science ®Google Scholar
• Cooper, H., Moore, L., Gruskin, S., & Krieger, N. (2005). The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: A qualitative study. Social Science & Medicine, 61(3), 673–684.
   PubMed Web of Science ®Google Scholar
• Cotten-Oldenburg, N. U., Carr, P., DeBoer, J. M., Collison, E. K., & Novotny, G. (2001). Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. Journal of Acquired Immune Deficiency Syndromes, 27(2), 183–192.
   PubMed Web of Science ®Google Scholar
• Coyle, S. L., Needle, R. H., & Normand, J. (1998). Outreach-based HIV prevention for injecting drug users: A review of published outcome data. Public Health Reports, 113(Suppl. 1), 19–30.
   PubMedGoogle Scholar
• Cunningham, C. O., Sohler, N. L., Berg, K. M., Shapiro, S., & Heller, D. (2006). Type of substance use and access to HIV-related health care. AIDS Patient Care and STDs, 20(6), 399–407.
   PubMed Web of Science ®Google Scholar
• Davis, C. S., Burris, S., Kraut-Becher, J., Lynch, K. G., & Metzger, D. (2005). Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. American Journal of Public Health, 95(2), 233–236.
   PubMed Web of Science ®Google Scholar
• De, P., Cox, J., Boivin, J. F., Platt, R. W., & Jolly, A. M. (2007). Rethinking approaches to risk reduction for injection drug users: Differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks. Journal of Acquired Immune Deficiency Syndromes, 46(3), 355–361.
   PubMed Web of Science ®Google Scholar
• Deren, S., Cleland, C. M., Fuller, C. M., Kang, S. Y., Des Jarlais, D. C., & Vlahov, D. (2006). The impact of syringe deregulation on sources of syringes for injection drug users: Preliminary findings. AIDS and Behavior, 10(6), 717–721.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Braine, N., & Friedmann, P. (2007). Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs. AIDS and Behavior, 11(6 Suppl.), 78–84.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Braine, N., Huso, Y., & Turner, C. (2007b). Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs. AIDS Education and Prevention, 19(2), 111–123.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Hagan, H., Arasteh, K., McKnight, C., Perlman, D., & Friedman, S. R. (2007c). Herpes simplex virus-2 and HIV among noninjecting drug users in New York city. Sexually Transmitted Diseases, 34(11), 923–927.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Kamyar, A., Perlis, T., Hagan, H., Abdul-Quader, A., Heckathorn, D., (2007d). Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS, 21, 231–235.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., McKnight, C., & Friedmann, P. (2002). Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001. Journal of the American Pharmaceutical Association (Washington, D.C.), 42(6 Suppl. 2), S73–S76.
   Google Scholar
• Des Jarlais, D. C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., (2004). “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. Journal of Acquired Immune Deficiency Syndromes, 35(2), 158–166.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Beatrice, S., Milliken, J., (2005). HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services. American Journal of Public Health, 95(8), 1439–1444.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Friedman, S. R., Chapman, T., Kwok, J., Rockwell, R., (2000). Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990–1997. American Journal of Public Health, 90(7), 1112–1116.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Friedman, S. R., Deren, S., Chapman, T., Sotheran, J. L., (1998). Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996. American Journal of Public Health, 88(12), 1801–1806.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Cooper, H. L., Tempalski, B., Keem, M., Friedman, R., Flom, P. L., (2006). Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS, 20(1), 93–99.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Lieb, S., Tempalski, B., Cooper, H., Keem, M., Friedman, R., (2005). HIV among injection drug users in large US metropolitan areas, 1998. Journal of Urban Health, 82(3), 434–445.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Tempalski, B., Cooper, H., Perlis, T., Keem, M., Friedman, R., (2004). Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. Journal of Urban Health, 81(3), 377–400.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Galea, S., Blaney, S., Ompad, D. C., Deren, S., Des Jarlais, D. C., (2004). Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity & Disease, 14(4), 589–596.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Galea, S., Caceres, W., Blaney, S., Sisco, S., & Vlahov, D. (2007). Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. American Journal of Public Health, 97(1), 117–124.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Vlahov, D., Latkin, C. A., Ompad, D. C., Celentano, D. D., & Strathdee, S. A. (2003). Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes, 32(1), 86–93.
   PubMed Web of Science ®Google Scholar
• Gallagher, K. M., Sullivan, P. S., Lansky, A., & Onorato, I. M. (2007). Behavioral surveillance among people at risk for HIV infection in the U.S.: The National HIV Behavioral Surveillance System. Public Health Reports, 122(Suppl. 1), 32–38.
   PubMed Web of Science ®Google Scholar
• Golub, E. T., Strathdee, S. A., Bailey, S. L., Hagan, H., Latka, M. H., Hudson, S. M., (2007). Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug and Alcohol Dependence, 91(Suppl. 1), S30–S38.
   PubMed Web of Science ®Google Scholar
• Hagan, H., Campbell, J. V., Thiede, H., Strathdee, S. A., Ouellet, L. J., Latka, M. H., (2007). Injecting alone among young adult IDUs in five US cities: Evidence of low rates of injection risk behavior. Drug and Alcohol Dependence, 91(Suppl. 1), S48–S55.
   PubMed Web of Science ®Google Scholar
• Heckathorn, D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174–199.
   Web of Science ®Google Scholar
• Heckathorn, D. (2002). Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems, 49(1), 11–34.
   Web of Science ®Google Scholar
• Heckathorn, D. (2007). Extensions of respondent-driven sampling: Analyzing continuous variables and controlling for differential recruitment. Sociological Methodology, 37(1), 151–207.
   Web of Science ®Google Scholar
• Heimer, R. (2005). Critical issues and further questions about respondent-driven sampling: Comment on Ramirez-Valles, et al. (2005). AIDS and Behavior, 9(4), 403–408; discussion 409–413.
   PubMed Web of Science ®Google Scholar
• Hennessy, R. R., Weisfuse, I. B., & Schlanger, K. (2007). Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care? Public Health Reports, 122(Suppl. 2), 31–35.
   PubMed Web of Science ®Google Scholar
• Huo, D., & Ouellet, L. J. (2007). Needle exchange and injection-related risk behaviors in Chicago: A longitudinal study. Journal of Acquired Immune Deficiency Syndromes, 45(1), 108–114.
   PubMed Web of Science ®Google Scholar
• Kang, S. Y., Deren, S., Andia, J., Colon, H. M., Robles, R., & Oliver-Velez, D. (2005). HIV transmission behaviors in jail/prison among Puerto Rican drug injectors in New York and Puerto Rico. AIDS and Behavior, 9(3), 377–386.
   PubMed Web of Science ®Google Scholar
• Kellerman, S. E., Drake, A., Lansky, A., & Klevens, R. M. (2006). Use of and exposure to HIV prevention programs and services by persons at high risk for HIV. AIDS Patient Care and STDs, 20(6), 391–398.
   PubMed Web of Science ®Google Scholar
• Kershaw, S. (2008). New HIV cases drop but rise in young gay men. New York Times, A24.
   Google Scholar
• Ksobiech, K. (2003). A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention, 15(3), 257–268.
   PubMed Web of Science ®Google Scholar
• Ksobiech, K. (2004). Assessing and improving needle exchange programs: Gaps and problems in the literature. Harm Reduction Journal, 1(4), 1–7.
   PubMedGoogle Scholar
• Lansky, A., Abdul-Quader, A. S., Cribbin, M., Hall, T., Finlayson, T. J., Garfein, R. S., (2007). Developing an HIV behavioral surveillance system for injecting drug users: The National HIV Behavioral Surveillance System. Public Health Reports, 122(Suppl. 1), 48–55.
   PubMed Web of Science ®Google Scholar
• Lansky, A., Sullivan, P. S., Gallagher, K. M., & Fleming, P. L. (2007). HIV behavioral surveillance in the U.S.: A conceptual framework. Public Health Reports, 122(Suppl. 1), 16–23.
   PubMed Web of Science ®Google Scholar
• Lorvick, J., Bluthenthal, R. N., Scott, A., Gilbert, M. L., Riehman, K. S., Anderson, R. L., (2006). Secondary syringe exchange among users of 23 California syringe exchange programs. Substance Use & Misuse, 41(6–7), 865–882.
   PubMed Web of Science ®Google Scholar
• Lurie, P., Jones, T. S., & Foley, J. (1998). A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl. 1), S45–S51.
   PubMedGoogle Scholar
• Magnani, R., Sabin, K., Saidel, T., & Heckathorn, D. (2005). Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS, 19(Suppl. 2), S67–S72.
   PubMed Web of Science ®Google Scholar
• Masson, C., Sorensen, J., Perlman, D., Shopshire, M., Delucchi, K., TeChieh, C., (2007). Hospital- versus community-based syringe exchange: A randomized controlled trial. AIDS Education and Prevention, 19(2), 97–110.
   PubMed Web of Science ®Google Scholar
• Metsch, L. R., Pereyra, M., Purcell, D. W., Latkin, C. A., Malow, R., Gomez, C. A., (2007). Correlates of lending needles/syringes among HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes, 46(Suppl. 2), S72–S79.
   PubMed Web of Science ®Google Scholar
• Metzger, D. S., & Navaline, H. (2003). HIV prevention among injection drug users: The need for integrated models. Journal of Urban Health, 4(Suppl. 3), iii59–iii66.
   Google Scholar
• Novelli, L. A., Sherman, S. G., Havens, J. R., Strathdee, S. A., & Sapun, M. (2005). Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug and Alcohol Dependence, 77(3), 303–309.
   PubMed Web of Science ®Google Scholar
• O'Connell, J. M., Kerr, T., Li, K., Tyndall, M. W., Hogg, R. S., Montaner, J. S., (2005). Requiring help injecting independently predicts incident HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes, 40(1), 83–88.
   PubMed Web of Science ®Google Scholar
• Osmond, D. H., Pollack, L. M., Paul, J. P., & Catania, J. A. (2007). Changes in prevalence of HIV infection and sexual risk behavior in men who have sex with men in San Francisco: 1997–2002. American Journal of Public Health, 97(9), 1677–1683.
   PubMed Web of Science ®Google Scholar
• Porter, J., Metzger, D., & Scotti, R. (2002). Bridge to services: Drug injectors’ awareness and utilization of drug user treatment and social service referrals, medical care, and HIV testing provided by needle exchange programs. Substance Use & Misuse, 37(11), 1305–1330.
   PubMed Web of Science ®Google Scholar
• Pouget, E. R., Deren, S., Fuller, C. M., Blaney, S., McMahon, J. M., Kang, S. Y., (2005). Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes, 39(4), 471–477.
   PubMed Web of Science ®Google Scholar
• Reich, W., Compton, W. M., Horton, J. C., Cottler, L. B., Cunningham-Williams, R. M., Booth, R., (2002). Injection drug users report good access to pharmacy sale of syringes. Journal of the American Pharmaceutical Association (Washington, D.C.), 42(6 Suppl. 2), S68–S72.
   Google Scholar
• Rhodes, T., Judd, A., Mikhailova, L., Sarang, A., Khutorskoy, M., Platt, L., (2004). Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: Maximizing the protective effects of syringe distribution. Journal of Acquired Immune Deficiency Syndromes, 35(3), 293–300.
   PubMed Web of Science ®Google Scholar
• Rhodes, T., Mikhailova, L., Sarang, A., Lowndes, C. M., Rylkov, A., Khutorskoy, M., (2003). Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science & Medicine, 57(1), 39–54.
   PubMed Web of Science ®Google Scholar
• Rich, J. D., Strong, L., Towe, C. W., & McKenzie, M. (1999). Obstacles to needle exchange participation in Rhode Island. Journal of Acquired Immune Deficiency Syndromes, 21(5), 396–400.
   PubMed Web of Science ®Google Scholar
• Rockwell, R., Deren, S., Goldstein, M. F., Friedman, S. R., & Des Jarlais, D. C. (2002). Trends in the AIDS epidemic among New York City's injection drug users: Localized or citywide? Journal of Urban Health, 79(1), 136–146.
   PubMed Web of Science ®Google Scholar
• Rothman, J., Rudnick, D., Slifer, M., Agins, B., Heiner, K., & Birkhead, G. (2007). Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990–2002: A model for effective service delivery to a high-risk population. Journal of Urban Health, 84(2), 226–242.
   PubMed Web of Science ®Google Scholar
• Rothman, K. J., & Greenland, S. (1998). Modern epidemiology. Philadelphia: Lippincott Williams.
   Google Scholar
• Salganik, M. J. (2006). Variance estimation, design effects, and sample size calculations for respondent-driven sampling. Journal of Urban Health, 83(6 Suppl.), 98–112.
   Web of Science ®Google Scholar
• Sanchez, T., Finlayson, T., Drake, A., Behel, S., Cribbin, M., Dinenno, E., (2006). Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors—United States, National HIV Behavioral Surveillance System: Men who have sex with men, November 2003–April 2005. MMWR. Surveillance Summaries, 55(6), 1–16.
   PubMedGoogle Scholar
• Santibanez, S. S., Garfein, R. S., Swartzendruber, A., Purcell, D. W., Paxton, L. A., & Greenberg, A. E. (2006). Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. Journal of Urban Health, 83(1), 86–100.
   PubMed Web of Science ®Google Scholar
• SAS Institute, Inc. (2005). Design and analysis of probability surveys. Cary, NC: SAS Institute.
   Google Scholar
• Somlai, A. M., Kelly, J. A., McAuliffe, T. L., Ksobiech, K., & Hackl, K. L. (2003). Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women. AIDS and Behavior, 7(4), 383–393.
   PubMed Web of Science ®Google Scholar
• Taussig, J. A., Weinstein, B., Burris, S., & Jones, T. S. (2000). Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS, 14(Suppl. 1), S47–S51.
   PubMed Web of Science ®Google Scholar
• Tempalski, B., Flom, P., Friedman, S. R., Des Jarlais, D. C., Friedman, J., McKnight, C., (2007). Social and political factors predicting the presence of syringe exchange programs in 96 U.S. metropolitan areas. American Journal of Public Health, 97(3), 437–447.
   PubMed Web of Science ®Google Scholar
• Thiede, H., Hagan, H., Campbell, J. V., Strathdee, S. A., Bailey, S. L., Hudson, S. M., (2007). Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug and Alcohol Dependence, 91(Suppl. 1), S39–S47.
   PubMed Web of Science ®Google Scholar
• Tortu, S., McMahon, J. M., Hamid, R., & Neaigus, A. (2003). Women's drug injection practices in East Harlem: An event analysis in a high-risk community. AIDS and Behavior, 7(3), 317–328.
   PubMed Web of Science ®Google Scholar
• van Ameijden, E. J., Krol, A., Vlahov, D., Flynn, C., van Haastrecht, H. J., & Coutinho, R. A. (1999). Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: An ecological comparison. Substance Use & Misuse, 34(6), 845–865.
   PubMed Web of Science ®Google Scholar
• Vlahov, D., Des Jarlais, D. C., Goosby, E., Hollinger, P. C., Lurie, P. G., Shriver, M. D., (2001). Needle exchange programs for the prevention of human immunodeficiency virus infection: Epidemiology and policy. American Journal of Epidemiology, 154(12 Suppl.), S70–S77.
   PubMedGoogle Scholar